To include your compound in the COVID-19 Resource Center, submit it here.
Aileron Therapeutics Inc. (Cambridge, Mass.) raised $30 million in a series E round. All of
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury